Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Ye

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|September 6, 2017
Considerations for pediatric trial designs and analysesMeehyung Cho, Zhiying Qiu, Jenny Ye, et al.
Journal of Diabetes and Its Complications|July 12, 2014
Equal improvement in glycaemia with lixisenatide given before breakfast or the main meal of the dayBo Ahrén, Natalia Vorokhobina, Elisabeth Souhami, et al.
Diabetes Care|May 1, 2013
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)Matthew C Riddle, Ronnie Aronson, Philip Home, et al.
Diabetes Care|May 26, 2016
Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 TrialJulio Rosenstock, Bruno Guerci, Markolf Hanefeld, et al.
The Journal of Investigative Dermatology|March 17, 2024
Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized StudyDedee F Murrell, Frédéric Caux, Aikaterini Patsatsi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|September 6, 2017
Considerations for pediatric trial designs and analysesMeehyung Cho, Zhiying Qiu, Jenny Ye, et al.
Journal of Diabetes and Its Complications|July 12, 2014
Equal improvement in glycaemia with lixisenatide given before breakfast or the main meal of the dayBo Ahrén, Natalia Vorokhobina, Elisabeth Souhami, et al.
Diabetes Care|May 1, 2013
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)Matthew C Riddle, Ronnie Aronson, Philip Home, et al.
Diabetes Care|May 26, 2016
Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 TrialJulio Rosenstock, Bruno Guerci, Markolf Hanefeld, et al.
The Journal of Investigative Dermatology|March 17, 2024
Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized StudyDedee F Murrell, Frédéric Caux, Aikaterini Patsatsi, et al.
Pageof 1